| Novel HPLC-UV method for simultaneous determination of valsartan and atenolol in fixed dosage form; Study of green profile assessment. K Peleshok, M Piponski, EA Ajie, O Poliak, N Zarivna, O Denefil, ... Pharmacia (0428-0296) 68 (1), 2021 | 16 | 2021 |
| Efficient validated HPLC/UV method for determination of valsartan and atenolol in dosage form and in vitro dissolution studies M Piponski, K Peleshok, L Logoyda, L Kravchuk, V Piatnochka, ... BRIAC 10, 6669-75, 2020 | 11 | 2020 |
| New liquid chromatography assays for simultaneous quantification of antihypertensives atenolol and valsartan in their dosage forms K Peleshok, M Piponski, S Kovalenko, H Ahmed, A Abdel‐Megied, ... Journal of Separation Science 44 (2), 565-575, 2021 | 8 | 2021 |
| Development of the spectrophotometric method for the determination of metoprolol tartrate in tablets by using bromocresol green M Horyn, T Kucher, L Kryskiw, O Poliak, N Zarivna, K Peleshok, ... ScienceRise: Pharmaceutical Science, 55-63, 2022 | 7 | 2022 |
| Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red K Peleshok, B Bondar, L Kryskiw, T Kucher, O Poliak, L Logoyda Pharmacia 68 (4), 851-858, 2021 | 6 | 2021 |
| Development and validation of spectrophotometric method for simultaneous estimation of valsartan and atenolol in binary mixtures: aplication to tablets analysis K Peleshok, O Poliak, L Kryskiw, AF Sarpong, N Zarivna, D Korobko, ... Pharmakeftiki 33 (1), 52-60, 2021 | 5 | 2021 |
| Development of the spectrophotometric method for the determination of metoprolol in tablets by using bromophenol blue M Horyn, L Kryskiw, T Kucher, O Poliak, N Zarivna, H Zahrychuk, ... ScienceRise: Pharmaceutical Science, 29-35, 2022 | 4 | 2022 |
| Quality control measurement and in vitro bioequivalence of valsartan and atenolol tablets marketed in Ukraine K Peleshok International Journal of Medicine and Medical Research 2, 52-58, 2020 | 3 | 2020 |
| Lc-ms/ms method development for the quantitative determination of valsartan from caco-2 cell monolayers: Application to permeability assay K Peleshok, O Poliak, N Zarivna, O Oleshchuk, U Mudryk, V Hlushok, ... Pharmakeftiki 33 (2), 107-115, 2021 | 2 | 2021 |
| Analytical support of innovative pharmaceutical development of antihypertensive drugs K Peleshok, N Shulyak, E Adaeze, A Donkor, J Oluwatobiloba, A Fatma, ... InterConf, 2021 | 1 | 2021 |
| Robustness evaluation of the chromatographic determination of valsartan in pharmaceuticals K Peleshok, O Dutchak, FA Mohamed Здобутки клінічної і експериментальної медицини, 26-31, 2020 | 1 | 2020 |
| Development and methodology for the estimation of atenolol and valsartan in pharmaceuticals KY Peleshok, LS Logoyda, OB Poliak Здобутки клінічної і експериментальної медицини, 30-33, 2020 | 1 | 2020 |
| АНАЛІТИЧНІ МЕТОДИКИ ВИЗНАЧЕННЯ ВАЛСАРТАНУ В ЛІКАРСЬКИХ ЗАСОБАХ:(ОГЛЯД ЛІТЕРАТУРИ) KY Peleshok Medical and Clinical Chemistry, 92-106, 2023 | | 2023 |
| Development and validation of spectrophotometric method for simultaneous estimation of valsartan and atenolol in dosage forms K Peleshok, L Kryskiw, S Kovalenko, L Logoyda ТНМУ, 2020 | | 2020 |
| ЮДЕН ТЕСТ ХРОМАТОГРАФІЧНОГО ВИЗНАЧЕННЯ АТЕНОЛОЛУ В ЛІКАРСЬКИХ ЗАСОБАХ KY Peleshok, DB Koval Medical and Clinical Chemistry, 61-65, 2020 | | 2020 |
